Quantum Biopharma Class B Subordinate Voting Shares
QNTM
12 hedge funds and large institutions have $192K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
21% more capital invested
Capital invested by funds: $159K → $192K (+$33.1K)
3.66% more ownership
Funds ownership: 0.04% → 3.7% (+3.7%)
14% less funds holding
Funds holding: 14 → 12 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$110K |
| 2 |
VF
Virtu Financial
New York
|
+$71.2K |
| 3 |
HF
HRT Financial
New York
|
+$61K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$536 |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$268 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$49.5K |
| 2 |
Jane Street
New York
|
-$17.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5.03K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.47K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.41K |
QNTM Hedge Fund Activity: Q3 2024 in Review
12 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2024, worth a combined $192K — up 21% from $159K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of QNTM and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was AdvisorShares Investments, adding an estimated $110K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $49.5K sold.
- 12 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $192K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2024, up 21% quarter-over-quarter.
- 4 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2024 and 6 closed out, a net change of -2 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2024 was AdvisorShares Investments, an estimated $110K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2024 was Renaissance Technologies, an estimated $49.5K sold.
Based on aggregated 13F filings for Q3 2024.